(1) Murtha LA et al. The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis. Front Physiol. (2017);8:777.
(2) Li X et al. Drugs and Targets in Fibrosis. Front Pharmacol. (2017);8:855.
(3) Falke LL et al. Diverse origins of the myofibroblast—implications for kidney fibrosis. Nat Rev Nephrol. (2015);11(4):233-44.
(4) Ng HH et al. Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways. Mol Cell Endocrinol. (2019);487:59-65.
(5) Piersma B et al. Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Front Med (Lausanne). (2015);2:59.